Skip to content
healthcare.dev

Naproxen

NDC 42192-619, Naproxen, suspension, from Acella Pharmaceuticals, LLC.

Product NDC
42192-619
Status
Listed
Labeler
Acella Pharmaceuticals, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA018965
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42192-619 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN125 mg/5mL

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
42192-619-1642192061916473 mL in 1 BOTTLE (42192-619-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7e6f03fb-4b36-4418-9684-f45637abbb78
  • NADAC price for package 42192061916

    GET /v1/drugs/nadac/42192061916

Use it

Look up 42192-619 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42192-619 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42192-619. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.